Truist Financial Corp Neogenomics Inc Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Truist Financial Corp holds 31,794 shares of NEO stock, worth $472,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,794

Previous 35,150 9.55%

Holding current value

$472,458

Previous $487,000 3.9%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $44,970 - $59,501	-3,356 Reduced 9.55%	31,794 $468,000
Q2 2024 Aug 20, 2024	SELL	$13.01 - $15.77 $61,133 - $74,103	-4,699 Reduced 11.79%	35,150 $487,000
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $25,434 - $30,373	1,809 Added 4.76%	39,849 $626,000
Q4 2023 Feb 02, 2024	BUY	$11.67 - $20.73 $87,011 - $154,562	7,456 Added 24.38%	38,040 $615,000
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $45,234 - $66,455	3,723 Added 13.86%	30,584 $376,000
Q2 2023 Aug 01, 2023	SELL	$14.1 - $19.83 $298,059 - $419,186	-21,139 Reduced 44.04%	26,861 $431,000
Q1 2023 May 05, 2023	BUY	$9.09 - $19.45 $1,554 - $3,325	171 Added 0.36%	48,000 $835,000
Q4 2022 Feb 17, 2023	SELL	$6.45 - $12.07 $709 - $1,327	-110 Reduced 0.23%	47,829 $441,000
Q3 2022 Oct 26, 2022	SELL	$7.86 - $12.91 $137,455 - $225,770	-17,488 Reduced 26.73%	47,939 $413,000
Q2 2022 Jul 22, 2022	SELL	$7.06 - $13.97 $92,613 - $183,258	-13,118 Reduced 16.7%	65,427 $534,000
Q1 2022 Apr 22, 2022	SELL	$12.15 - $35.28 $307,698 - $893,466	-25,325 Reduced 24.38%	78,545 $954,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $189,068 - $300,686	-6,201 Reduced 5.63%	103,870 $3.54 Million
Q3 2021 Nov 05, 2021	SELL	$41.66 - $52.52 $1.01 Million - $1.28 Million	-24,290 Reduced 18.08%	110,071 $5.31 Million
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $267,838 - $378,060	7,314 Added 5.76%	134,361 $6.07 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $985,387 - $1.42 Million	23,710 Added 22.94%	127,047 $6.13 Million
Q4 2020 Nov 19, 2021	SELL	$36.08 - $56.47 $272,043 - $425,783	-7,540 Reduced 6.8%	103,337 $5.56 Million
Q4 2020 Feb 18, 2021	BUY	$36.08 - $56.47 $537,014 - $840,499	14,884 Added 15.51%	110,877 $5.97 Million
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $258,263 - $314,327	-7,765 Reduced 7.48%	95,993 $3.54 Million
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $27,647 - $35,424	-1,142 Reduced 1.09%	103,758 $3.21 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $158,403 - $266,813	7,727 Added 7.95%	104,900 $2.9 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $1.84 Million - $2.9 Million	97,173 New	97,173 $2.84 Million

Others Institutions Holding NEO

# of Institutions

292

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.87B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Neogenomics Inc Transaction History